ENTITY

Xizang Haisco Pharmaceutical Group Co (002653 CH)

16
Analysis
Health CareChina
Xizang Haisco Pharmaceutical Group Company Limited develops, manufactures and sells drug formulations and active pharmaceutical ingredients. The Company's main products include hepatobiliary disease medication, anti-infective drugs, parenteral nutrition drugs, invert sugar for injection, and other related products.
more
Refresh
31 Oct 2022 05:24

CSI500 Index Rebalance Preview: 50 Adds/Deletes in December

We expect 50 adds/deletes at the December rebalance with one-way turnover expected to be over 13% & the one-way trade around CNY 8bn. There is a...

Logo
376 Views
Share
29 Jun 2020 23:52

Global Equity Chart Book: Stick With EM Over EAFE

With RS uptrends intact we continue to recommend Sector overweights to MSCI EM Technology, Consumer Discretionary, Health Care, and Communications....

Logo
393 Views
Share
25 Oct 2016 12:40

Key Drivers of Asia's Healthcare Sector

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...

Share
06 Oct 2016 21:27

Falling Fertility Adds to China's Population Woes

By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...

Logo
Bixmoor
4.1k Views
Share
12 Sep 2016 23:18

Iran Shows China the Way on Population Expansion

Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...

Logo
Bixmoor
188 Views
Share
x